The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
FXR Acetylation Is Normally Dynamically Regulated by p300 and SIRT1 but Constitutively Elevated in Metabolic Disease States
Open accessAbstract
The nuclear bile acid receptor FXR is critical for regulation of lipid and glucose metabolism. Here, we report that FXR is a target of SIRT1, a deacetylase that mediates nutritional and hormonal modulation of hepatic metabolism. Lysine 217 of FXR is the major acetylation site targeted by p300 and SIRT1. Acetylation of FXR increases its stability but inhibits heterodimerization with RXRalpha, DNA binding, and transactivation activity. Downregulation of hepatic SIRT1 increased FXR acetylation with deleterious metabolic outcomes. Surprisingly, in mouse models of metabolic disease, FXR interaction with SIRT1 and p300 was dramatically altered, FXR acetylation levels were elevated, and overexpression of SIRT1 or resveratrol treatment reduced acetylated FXR levels. Our data demonstrate that FXR acetylation is normally dynamically regulated by p300 and SIRT1 but is constitutively elevated in metabolic disease states. Small molecules that inhibit FXR acetylation by targeting SIRT1 or p300 may be promising therapeutic agents for metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been demonstrated that the gene encoding FMO3 is a direct FXR target gene, and FXR has been found to be a target of sirtuin 1 (SIRT1) in metabolic regulation (23, 34, 35).”
In the citing paper
“Moreover, RSV increased the expression and activity of FMO3 in the liver, corresponding with previously published results (34).”
In the citing paper
“It has been demonstrated that the gene encoding FMO3 is a direct FXR target gene, and FXR has been found to be a target of sirtuin 1 (SIRT1) in metabolic regulation (23, 34, 35).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,165
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors
Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487
Mammalian SIRT1 Represses Forkhead Transcription Factors
Motta, M. C., Divecha, N., Lemieux, M. E., Kamel, C., Chen, D., Gu, W. J., Bultsma, Y., McBurney, M. W., & Guarente, L. (2004) · Cell · doi:10.1016/s0092-8674(04)00126-6 · Cited by 1,366
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164 · cited 2×
“, 2006) and protection of intestines from intestinal bacteria growth (Inagaki et al., 2006).”
Background
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 330
Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development
Li, T., & Chiang, J. Y. L. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.000978 · Cited by 85
Post-translational modification of pregnane x receptor
Staudinger, J. L., Xu, C., Biswas, A., & Mani, S. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.02.011 · Cited by 77
Kazgan, N., Metukuri, M. R., Purushotham, A., Lü, J., Rao, A., Lee, S., Pratt–Hyatt, M., Lickteig, A. J., Csanaky, I. L., Zhao, Y., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.029 · Cited by 74
Byun, S., Kim, D.-H., Ryerson, D., Kim, Y., Sun, H., Kong, B., Yau, P. M., Guo, G. L., Xu, H. E., KEMPER, B. W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04697-5 · Cited by 76
Self-citationRegulation of bile acid receptor activity
Wan, Y. Y., & Sheng, L. (2018) · Liver Research · doi:10.1016/j.livres.2018.09.008 · Cited by 75
SIRT1 is a Direct Coactivator of Thyroid Hormone Receptor β1 with Gene-Specific Actions
Suh, J. H., Sieglaff, D. H., Zhang, A., Xia, X., Čvoro, A., Winnier, G. E., & Webb, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070097 · Cited by 76
Kulkarni, S. R., Soroka, C. J., Hagey, L. R., & Boyer, J. L. (2016) · Hepatology · doi:10.1002/hep.28826 · Cited by 73
Berrabah, W., Aumercier, P., Gheeraert, C., Dehondt, H., Bouchaert, E., Alexandre, J., Ploton, M., Mazuy, C., Caron, S., Tailleux, A., et al. (2013) · Hepatology · doi:10.1002/hep.26710 · Cited by 71
Alshehri, A. S., El-kott, A. F., El-Kenawy, A. E.-M., Khalifa, H. S., & Al‐Ramlawy, A. M. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.147182 · Cited by 73
Wu, S., Cui, S., Wang, L., Zhang, Y., Yan, X., Lu, H., Xing, G., Ren, J., & Gong, L. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0110-y · Cited by 70
Self-citationA postprandial FGF19‐SHP‐LSD1 regulatory axis mediates epigenetic repression of hepatic autophagy
Byun, S., Kim, Y., Zhang, Y., Kong, B., Guo, G. L., Sadoshima, J., Ma, J., KEMPER, B. W., & Kemper, J. K. (2017) · The EMBO Journal · doi:10.15252/embj.201695500 · Cited by 69
Self-citationCelastrol Protects From Cholestatic Liver Injury Through Modulation of SIRT1-FXR Signaling
Zhao, Q., Liu, F., Cheng, Y., Xiao, X.-R., Hu, D., Tang, Y., Bao, W.-M., Yang, J., Jiang, T., Hu, J., et al. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000817 · Cited by 68
Bao, J., & Sack, M. N. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0402-y · Cited by 67
Acetylation and nuclear receptor action
Wang, C., Tian, L., Popov, V. M., & Pestell, R. G. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.12.003 · Cited by 71
Role of farnesoid X receptor in inflammation and resolution
Shaik, F. B., Prasad, D. V. R., & Narala, V. R. (2014) · Inflammation Research · doi:10.1007/s00011-014-0780-y · Cited by 69
Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
Girisa, S., Henamayee, S., Parama, D., Rana, V., Dutta, U., & Kunnumakkara, A. B. (2021) · Molecular Biomedicine · doi:10.1186/s43556-021-00035-2 · Cited by 67
SIRT1 is a Highly Networked Protein That Mediates the Adaptation to Chronic Physiological Stress
McBurney, M. W., Clark-Knowles, K. V., Caron, A. Z., & Gray, D. A. (2013) · Genes & Cancer · doi:10.1177/1947601912474893 · Cited by 69
Bukke, V. N., Moola, A., Serviddio, G., Vendemiale, G., & Bellanti, F. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i48.6909 · Cited by 69
Kemper, J. K., Choi, S.-E., & Kim, D.-H. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00016-x · Cited by 65
Self-citationPloton, M., Mazuy, C., Gheeraert, C., Dubois, V., Berthier, A., Dubois-Chevalier, J., Maréchal, X., Bantubungi, K., Diemer, H., Cianférani, S., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.022 · Cited by 63
Biswas, A., Pasquel, D., Tyagi, R. K., & Mani, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.048 · Cited by 61
Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivation
Chanda, D., Xie, Y., & Choi, H.-S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq227 · Cited by 61
Crucial Roles for SIRT2 and AMPA Receptor Acetylation in Synaptic Plasticity and Memory
Wang, G., Li, S., Gilbert, J. P., Gritton, H. J., Wang, Z., Li, Z., Han, X., Selkoe, D. J., & Man, H. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.030 · Cited by 61
Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease
Heebøll, S. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i4.188 · Cited by 60
p300 in Cardiac Development and Accelerated Cardiac Aging
Ghosh, A. K. (2020) · Aging and Disease · doi:10.14336/ad.2020.0401 · Cited by 59
Purushotham, A., Xu, Q., & Li, X. (2011) · The FASEB Journal · doi:10.1096/fj.11-195172 · Cited by 60
Activation of Sirt1/FXR Signaling Pathway Attenuates Triptolide-Induced Hepatotoxicity in Rats
Yang, J., Sun, L., Wang, L., Hassan, H. M., Wang, X., Hylemon, P. B., Wang, T., Zhou, H., Zhang, L., & Jiang, Z. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00260 · Cited by 60
Pathophysiology of the aging kidney and therapeutic interventions
Kanasaki, K., Kitada, M., & Koya, D. (2012) · Hypertension Research · doi:10.1038/hr.2012.159 · Cited by 58
Yang, J., Xiang, D., Xiang, D., He, W., Liu, Y., Lan, L., Li, G., Jiang, C., Ren, X., Liu, D., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01685 · Cited by 56
SRT1720 Alleviates ANIT-Induced Cholestasis in a Mouse Model
Yu, L., Liu, X., Yuan, Z., Li, X., Yang, H., Yuan, Z., Sun, L., Zhang, L., & Jiang, Z. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00256 · Cited by 55
Balasubramaniyan, N., Ananthanarayanan, M., & Suchy, F. J. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00441.2011 · Cited by 57
The sirtuin class of histone deacetylases: Regulation and roles in lipid metabolism
Fiorino, E., Giudici, M., Ferrari, A., Mitro, N., Caruso, D., Fabiani, E. D., & Crestani, M. (2014) · IUBMB Life · doi:10.1002/iub.1246 · Cited by 54
Wei, D., Tao, R., Zhang, Y., White, M. F., & Dong, X. C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00524.2010 · Cited by 52
Prawitt, J., Caron, S., & Staels, B. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.03.007 · Cited by 55
Zeng, X., Zhou, X., Xu, J., Chan, S. M. H., Xue, C. C., Molero, J. C., & Ye, J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.07.003 · Cited by 49
Transcriptional Co-activator p300 Maintains Basal Hepatic Gluconeogenesis
He, L., Naik, K., Meng, S., Cao, J., Sidhaye, A. R., Ma, A., Radovick, S., & Wondisford, F. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.385864 · Cited by 47
SIRT1: a promising therapeutic target in type 2 diabetes mellitus
Mihanfar, A., Akbarzadeh, M., Darband, S. G., Sadighparvar, S., & Majidinia, M. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1956976 · Cited by 51
Curtil, C., Enache, L. S., Radreau, P., Anne-Gaëlle, D., Scholtès, C., Deloire, A., Roche, D., Lotteau, V., André, P., & Ramière, C. (2013) · The FASEB Journal · doi:10.1096/fj.13-236372 · Cited by 50
Ding, Z., Cao, J., Shen, Y., Zou, Y., Yang, X., Zhou, W., Guo, Q., & Huang, C. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00341 · Cited by 51
Formononetin ameliorates cholestasis by regulating hepatic SIRT1 and PPARα
Yang, S., Wei, L., Xia, R., Liu, L., Chen, Y., Zhang, W., Li, Q., Feng, K., Yu, M., Zhang, W., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.131 · Cited by 48
Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
Zhou, M., Wang, D., Li, X., Cao, Y., Yi, C., Ocansey, D. K. W., Zhou, Y., & Mao, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1016836 · Cited by 49
Sabir, M. S., Khan, Z., Hu, C., Galligan, M. A., Dussik, C. M., Mallick, S., Stone, A. D., Batie, S. F., Jacobs, E. T., Whitfield, G. K., et al. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.06.010 · Cited by 45
Zhu, L., Wang, L., Cao, F., Liu, P., Bao, H., Yan, Y., Dong, X., Wang, D., Wang, Z., & Gong, P. (2018) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.537 · Cited by 47
Byun, S., Jung, H.-K., Chen, J., Kim, Y., Kim, D.-H., Kong, B., Guo, G. L., KEMPER, B. W., & Kemper, J. K. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008360 · Cited by 47
Self-citationFine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease
Blokker, B. A., Maijo, M., Echeandia, M., Galduroz, M., Patterson, A. M., Ten, A., Philo, M., Schungel, R., Gutierrez‐de Juan, V., Halilbasic, E., et al. (2019) · Hepatology · doi:10.1002/hep.30275 · Cited by 46
Posttranslational Modifications of Lipid-Activated Nuclear Receptors: Focus on Metabolism
Bécares, N., Gage, M., & Pineda‐Torra, I. (2016) · Endocrinology · doi:10.1210/en.2016-1577 · Cited by 50
Choi, S., Kwon, S., Seok, S., Xiao, Z., Lee, K. W., KANG, Y. Y., Li, X., Shinoda, K., Kajimura, S., KEMPER, B. W., et al. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00006-17 · Cited by 46
Self-citationMetabolic Effects of Bile Acids: Potential Role in Bariatric Surgery
Flynn, C. R., Albaugh, V. L., & Abumrad, N. N. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.04.014 · Cited by 48
Zhou, F., Liu, Q., Zhang, L., Zhu, Q., Wang, S., Zhu, K., Deng, R., Liu, Y., Yuan, G., Wang, X. D., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02960-6 · Cited by 45
Endoplasmic reticulum stress actively suppresses hepatic molecular identity in damaged liver
Dubois, V., Gheeraert, C., Vankrunkelsven, W., Dubois‐Chevalier, J., Dehondt, H., Bobowski‐Gerard, M., Vinod, M., Zummo, F. P., Güiza, F., Ploton, M., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199156 · Cited by 46
Self-citationDeleted in breast cancer-1 (DBC-1) in the interface between metabolism, aging and cancer
Chini, E. N., Chini, C. C. S., Nin, V., & Escande, C. (2013) · Bioscience Reports · doi:10.1042/bsr20130062 · Cited by 46
Kim, Y., Fang, S., Byun, S., Seok, S., KEMPER, B. W., & Kemper, J. K. (2014) · Hepatology · doi:10.1002/hep.27677 · Cited by 44
Self-citationBazrgar, M., Khodabakhsh, P., Prudencio, M., Mohagheghi, F., & Ahmadiani, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105805 · Cited by 45
Seok, S., Kanamaluru, D., Xiao, Z., Ryerson, D., Choi, S., Suino-Powell, K. M., Xu, H. E., Veenstra, T. D., & Kemper, J. K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.452037 · Cited by 42
Self-citationEpigenetic regulation by polyphenols in diabetes and related complications
Ullah, H., Filippis, A. D., Santarcangelo, C., & Daglia, M. (2020) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-200489 · Cited by 43
Liu, S., Fang, X., Wen, X., Liu, J.-S., Alip, M., Sun, T., Wang, Y. Y., & Chen, H. (2024) · World Journal of Stem Cells · doi:10.4252/wjsc.v16.i3.245 · Cited by 44
Sirt1-Independent Mechanisms of the Putative Sirtuin Enzyme Activators SRT1720 and SRT2183
Huber, J. L., McBurney, M. W., DiStefano, P. S., & McDonagh, T. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.257 · Cited by 43
Park, J.-M., Kim, T. H., JO, S., Kim, M.-Y., & Ahn, Y. (2015) · Scientific Reports · doi:10.1038/srep17395 · Cited by 42
A wheel of time: the circadian clock, nuclear receptors, and physiology: Figure 1.Preprint
Yang, X. (2010) · Genes & Development · doi:10.1101/gad.1920710 · Cited by 43
The Farnesoid X Receptor as a Master Regulator of Hepatotoxicity
Rausch, M., Samodelov, S. L., Visentin, M., & Kullak-Ublick, G. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213967 · Cited by 44
Tian, L., Wang, C., Hagen, F. K., Gormley, M., Addya, S., Soccio, R. E., Casimiro, M. C., Zhou, J., Powell, M. J., Xu, P., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2371 · Cited by 41
p300/CBP as a Key Nutritional Sensor for Hepatic Energy Homeostasis and Liver Fibrosis
Yao, W., Wang, T., & Huang, F. (2018) · BioMed Research International · doi:10.1155/2018/8168791 · Cited by 42
Attia, Y. M., Tawfiq, R. A., Gibriel, A. A., Ali, A. A., Kassem, D. H., Hammam, O. A., & Elmazar, M. M. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114497 · Cited by 39
Pittala, S., Krelin, Y., Kuperman, Y., & Shoshan‐Barmatz, V. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.06.017 · Cited by 41
Cui, S., Hu, H., Chen, A., Cui, M., Pan, X., Zhang, P., Wang, G., Wang, H., & Hao, H. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.019 · Cited by 39
Regulation of Liver Glucose and Lipid Metabolism by Transcriptional Factors and Coactivators
Ramatchandirin, B., Pearah, A., & He, L. (2023) · Life · doi:10.3390/life13020515 · Cited by 45
Chini, C. C. S., Escande, C., Nin, V., & Chini, E. N. (2013) · Biochemical Journal · doi:10.1042/bj20121085 · Cited by 39
Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders
Appelman, M. D., van der Veen, S. W., & van Mil, S. W. C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.729828 · Cited by 38
Kim, Y., Jung, H.-K., Seok, S., Zhang, Y., Ma, J., Li, T., KEMPER, B. W., & Kemper, J. K. (2019) · Hepatology · doi:10.1002/hep.30966 · Cited by 34
Self-citationThe Protective Effects of Imperatorin on Acetaminophen Overdose-Induced Acute Liver Injury
Gao, Z., Zhang, J., Li, W., Yang, X., Zhang, Y., Cheng, B., Yang, Z., Gao, W., Song, C., Miao, W., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8026838 · Cited by 37
RetractedWang, C., Zhang, F., Wang, L., Zhang, Y., Li, X., Huang, K., Du, M., Liu, F., Huang, S., Guan, Y., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00160-13 · Cited by 37
Qin, T., Hasnat, M., Wang, Z., Hassan, H. M., Zhou, Y., Yuan, Z., & Zhang, W. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154971 · Cited by 36
Nishimura, Y., Sasagawa, S., Ariyoshi, M., Ichikawa, S., Shimada, Y., Kawaguchi, K., Kawase, R., Yamamoto, R., Uehara, T., Yanai, T., et al. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00199 · Cited by 36
Wu, Y., Meng, X., Huang, C. Z., & Li, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-3488-x · Cited by 36
Romagnolo, D. F., Zempleni, J., & Selmin, O. I. (2014) · Advances in Nutrition · doi:10.3945/an.114.005868 · Cited by 36
Epigenomic regulation of bile acid metabolism: Emerging role of transcriptional cofactors
Smith, Z., Ryerson, D., & Kemper, J. K. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.04.008 · Cited by 36
Self-citationMicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1
Xu, J., Liu, P., Si, M.-J., & Ding, X. (2013) · Tumor Biology · doi:10.1007/s13277-013-0974-x · Cited by 36
RetractedYe, M., Fan, M., Zhao, Y., Wang, F., Yang, X., Yao, W., Gao, X., Yu, J., & Liu, W. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.124050 · Cited by 35
Role of Sirtuins in Maintenance of Genomic Stability: Relevance to Cancer and Healthy Aging
Wu, X., Neng, C., Fenech, M. F., & Wang, X. (2016) · DNA and Cell Biology · doi:10.1089/dna.2016.3280 · Cited by 33
Down-Regulation of SIRT1 Expression by mir-23b Contributes to Lipid Accumulation in HepG2 Cells
Borji, M., Nourbakhsh, M., Shafiee, S. M., Owji, A. A., Abdolvahabi, Z., Hesari, Z., Ilbeigi, D., Seiri, P., & Yousefi, Z. (2019) · Biochemical Genetics · doi:10.1007/s10528-019-09905-5 · Cited by 33
Bile acid treatment and FXR agonism lower postprandial lipemia in mice
Farr, S., Stankovic, B., HOFFMAN, S. S., Masoudpoor, H., Baker, C., Taher, J., Dean, A. E., Anakk, S., & Adeli, K. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00386.2018 · Cited by 35
He, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042121 · Cited by 35
Kanamaluru, D., Xiao, Z., Fang, S., Choi, S., Kim, D.-H., Veenstra, T. D., & Kemper, J. K. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01212-10 · Cited by 35
Self-citationXia, J., Tang, N., Wu, X., & Ren, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1033145 · Cited by 32
Epigenetic regulation of drug processing genes
Klaassen, C. D., Lü, H., & Cui, J. Y. (2011) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2011.562758 · Cited by 32
Jung, H.-K., Chen, J., Hu, X., Sun, H., Wu, S.-Y., Chiang, C., KEMPER, B. W., Chen, L., & Kemper, J. K. (2020) · JCI Insight · doi:10.1172/jci.insight.141640 · Cited by 30
Self-citationSirt1 exerts anti-inflammatory effects and promotes steroidogenesis in Leydig cells
Wu, L., Zhang, A., Sun, Y., Zhu, X., Fan, W., Lu, X., Yang, Q., & Feng, Y. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.04.008 · Cited by 32
Cheng, Y., Xiang, X., Liu, C., Cai, T., Li, T., Chen, Y., Bai, J., Shi, H., Zheng, T., Huang, M., et al. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c05591 · Cited by 31
A SUMO-acetyl switch in PXR biology
Cui, W., Sun, M., Zhang, S., Shen, X., Galeva, N. A., Williams, T. D., & Staudinger, J. L. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.02.008 · Cited by 30
Resveratrol promotes degradation of the human bile acid transporter ASBT (SLC10A2)
Chothe, P. P., & Swaan, P. W. (2014) · Biochemical Journal · doi:10.1042/bj20131428 · Cited by 29
Lin, C., Zeng, H., Lu, J., Xie, Z., Sun, W., Luo, C., Ding, J., Yuan, S., Geng, M., & Huang, M. (2015) · Oncotarget · doi:10.18632/oncotarget.3987 · Cited by 28
Zhao, K., Liu, S., Chen, Y., Yao, Y., Zhou, M., Yuan, Y., Wang, Y., Pei, R., Chen, J., Hu, X., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0189-8 · Cited by 29
Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic Disease
van Zutphen, T., Bertolini, A., de Vries, H. D., Bloks, V. W., de Boer, J. F., Jonker, J. W., & Kuipers, F. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_233 · Cited by 31
Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer
Jaiswal, B., Agarwal, A., & Gupta, A. K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.886594 · Cited by 29
Role of FXR in Renal Physiology and Kidney Diseases
Guo, Y., Xie, G., & Zhang, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032408 · Cited by 33
ERRγ suppression by Sirt6 alleviates cholestatic liver injury and fibrosis
Hao, L., Bang, I. H., Wang, J., Mao, Y., Yang, J. D., Na, S., Seo, J. K., Choi, H., Bae, E. J., & Park, B. (2020) · JCI Insight · doi:10.1172/jci.insight.137566 · Cited by 29
Transcriptional Regulation of Metabolism by SIRT1 and SIRT7
Yamagata, K., & Yoshizawa, T. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.07.009 · Cited by 30
Genetic analysis of the SIRT1 gene promoter in myocardial infarction
Cui, Y., Wang, H., Chen, H., Pang, S., Wang, L., Liu, D., & Yan, B. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.071 · Cited by 28
MicroRNAs in heart failure: Non-coding regulators of metabolic function
Zhang, X., & Schulze, P. C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.009 · Cited by 28
Acetylation of nuclear receptors in health and disease: an update
Ashton, A. W., Dhanjal, H. K., Rossner, B., Mahmood, H., Patel, V. I., Mohammad, N., Lota, M., Shahid, F., Li, Z., Joyce, D. A., et al. (2022) · FEBS Journal · doi:10.1111/febs.16695 · Cited by 27
Metadata
- Authors
- Kemper, J. K., Xiao, Z., Ponugoti, B., Miao, J., Fang, S., Kanamaluru, D., Tsang, S., Wu, S.-Y., Chiang, C.-M., & Veenstra, T. D.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Frederick National Laboratory for Cancer Research (US)
- Harold C. Simmons Comprehensive Cancer Center (US)
- Corresponding author
- Kemper, Jongsook Kim
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 10
- Issue
- 5
- Pages
- 392-404
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC2785075
- OpenAlex
- W1983620925
- Cited by
- 332
- References
- 39
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 10 · 2023: 15 · 2022: 17 · 2021: 16 · 2020: 22 · 2019: 20 · 2018: 23 · 2017: 22 · 2016: 15 · 2015: 18 · 2014: 29 · 2013: 29 · 2012: 30
- FWCI
- 16.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DigitalCommons-Cedarville (Cedarville University) (submittedVersion)
- Funders
- National Institutes of Health (n01co12400-79-0-22)
- National Cancer Institute (N01CO12400, N01-CO-012400, CA103867, R01CA103867, R01CA124760, CA124760)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK062777, R01DK080032, DK062777, R56DK062777, DK80032)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- farnesoid X receptor, protein acetylation, P300, SIRT1, receptor stability, DNA binding, transcriptional activation, hepatic metabolism, metabolic disorders, resveratrol, small molecule drugs
- MeSH terms
- Resveratrol, Receptor, Farnesoid X-Activated, p300-CBP-Associated Factor, Acetylation, Animals, Disease Models, Animal, Histone Deacetylases, Liver, Liver Diseases, Male, Stilbenes, Transcription Factors, Transcriptional Activation, Down-Regulation, Mutagenesis, Site-Directed, Receptors, Cytoplasmic and Nuclear, Dimerization, RNA, Small Interfering, Retinoid X Receptor alpha, p300-CBP Transcription Factors, Mice, Protein Stability, Sirtuin 1, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review